Your browser doesn't support javascript.
loading
Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection.
Minutolo, Antonella; Petrone, Vita; Fanelli, Marialaura; Maracchioni, Christian; Giudice, Martina; Teti, Elisabetta; Coppola, Luigi; Sorace, Chiara; Iannetta, Marco; Tony Miele, Martino; Bernardini, Sergio; Mastino, Antonio; Sinibaldi Vallebona, Paola; Balestrieri, Emanuela; Andreoni, Massimo; Sarmati, Loredana; Grelli, Sandro; Garaci, Enrico; Matteucci, Claudia.
Afiliação
  • Minutolo A; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy. Electronic address: antonella.minutolo@uniroma2.it.
  • Petrone V; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Fanelli M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Maracchioni C; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Giudice M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Teti E; Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy.
  • Coppola L; Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy.
  • Sorace C; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Iannetta M; Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Tony Miele M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Bernardini S; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Mastino A; Institute of Translational Pharmacology, National Research Council, Rome 00133, Italy.
  • Sinibaldi Vallebona P; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy; Institute of Translational Pharmacology, National Research Council, Rome 00133, Italy.
  • Balestrieri E; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Andreoni M; Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Sarmati L; Infectious Diseases Clinic, Tor Vergata Hospital, Rome 00133, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
  • Grelli S; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy; Virology Unit, Tor Vergata Hospital, Rome 00133, Italy.
  • Garaci E; IRCCS San Raffaele Pisana, Rome 00163, Italy.
  • Matteucci C; Department of Experimental Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
Int Immunopharmacol ; 118: 110055, 2023 May.
Article em En | MEDLINE | ID: mdl-36989892
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timosina / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Timosina / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article